En este caso, existe otro factor preocupante. Merck y Schering-Plouh, que operan de consuno, revelaron este martes que habían modificado los “fines primarios”, o sea los resultados eventualmente ...
In a report released on October 4, Carter Gould from Barclays maintained a Buy rating on Merck & Company (MRK – Research Report), with a price target of $140.00. The company’s shares closed ...
(RTTNews) - Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development collaboration to evaluate the combination of Exelixis ...
German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...
British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of ...
It spiked after the company released late-stage trial data showing one of its drugs, Ivonescimab, performed better than Merck's blockbuster Keytruda medication in some lung cancer patients.
German science and technology company Merck lowered mid-term targets for its Life Sciences and Healthcare businesses, ...
Merck's recent decline is due to reduced profit guidance and FDA decisions, but shares are at a support level that is likely to hold. Keytruda remains a key revenue driver, with potential for ...
Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...
The global Cattle & Porcine/Swine Reproductive Diseases market is expected to grow to USD 975.8 Million by 2029, up from USD ...
Aquí tienes una recopilación con todos los logos de coches, un artículo en el que encontrarás los emblemas de las marcas de automóviles más destacadas de cuantas operan en el mercado ...
Bristol Myers Squibb's (NYSE:BMY) Opdivo (nivolumab) and Merck's (NYSE:MRK) Keytruda (pembrolizumab), two highly popular checkpoint inhibitors used in the treatment of various types of cancer ...